logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Neoplasms

    FiltersReset Filters
    51 results

    • aminocaproic acid

      (AMINOCAPROIC ACID)
      Biocon Pharma Inc.
      Usage: Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.

    • axtle

      (pemetrexed)
      Avyxa Pharma, LLC
      Usage: AXTLE is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, maintenance therapy after prior chemotherapy, and for recurrent NSCLC. It also treats unresectable malignant pleural mesothelioma in combination with cisplatin. Not for squamous NSCLC.

    • dactinomycin

      (DACTINOMYCIN)
      Eugia US LLC
      Usage: Dactinomycin for injection is indicated for treating Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, metastatic nonseminomatous testicular cancer, and gestational trophoblastic neoplasia in adults and children. It is also used for regional perfusion in adults with locally recurrent or locoregional solid malignancies as part of palliative care.

    • dexamethasone

      (dexamethasone)
      Amneal Pharmaceuticals NY LLC
      Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.

    • e-z-hd

      (barium sulfate)
      E-Z-EM Canada Inc
      Usage: E-Z-HD is indicated for double-contrast radiographic examinations of the esophagus, stomach, and duodenum, aiding visualization of the gastrointestinal tract in patients aged 12 and older.

    • edecrin

      (ethacrynic acid)
      Bausch Health US, LLC
      Usage: EDECRIN is indicated for treating edema related to congestive heart failure, cirrhosis, renal disease, and nephrotic syndrome. It also manages ascites, idiopathic edema, and lymphedema, particularly in hospitalized pediatric patients. Intravenous use is designated for rapid diuresis in acute situations or when oral administration is not an option.

    • ethacrynic acid

      (Ethacrynic Acid)
      ScieGen Pharmaceuticals Inc
      Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.

    • ethacrynic acid

      (Ethacrynic Acid)
      Amneal Pharmaceuticals NY LLC
      Usage: Ethacrynic acid tablets are indicated for edema treatment requiring stronger diuretics, including conditions like congestive heart failure, cirrhosis, renal disease, ascites, and more. Intravenous formulation is used for rapid diuresis or when oral administration is not feasible, such as in acute pulmonary edema.

    • fludeoxyglucose

      (Fludeoxyglucose F18)
      MIPS Cyclotron & Radiochemistry Facility
      Usage: Fludeoxyglucose F18 Injection is indicated for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology for evaluating left ventricular function in coronary artery disease, and in neurology to identify abnormal glucose metabolism related to epileptic seizures.

    • fludeoxyglucose

      (Fludeoxyglucose F18)
      Kreitchman PET Center
      Usage: Fludeoxyglucose F18 Injection is used for PET imaging to assess abnormal glucose metabolism in oncology (evaluating malignancy), cardiology (identifying myocardial metabolism in coronary artery disease), and neurology (locating abnormal glucose metabolism related to epileptic seizures).